Research
Since Jack’s diagnosis, there have been no additional reports detailing the phenotype or prognosis for SCAR-15 published in literature. Given that the RUBCN gene was only recently upgraded to a causative disease gene, this condition is likely underdiagnosed in the general population.
We expect to learn more about SCAR-15 as more cases come to clinical attention.
SCAR-15 RESEARCH UPDATE
Laying the Groundwork
Research on Spinocerebellar Ataxia Recessive Type 15 (SCAR-15) is actively moving forward. Right now, several projects are focused on building the scientific tools needed to better understand the disease and move toward future therapies.
Although there are currently no approved treatments for SCAR-15, important foundational work is underway. Our three funded research grants are focused on critical first steps in rare disease research: developing and studying models that allow scientists to understand how the disease works and identifying potential therapeutic strategies.
This stage of research lays the groundwork for everything that follows in treatment
development.
SCAR-15 Path To A Cure
Currently we are at Step 1 — We need your support to reach our goal of finding a cure.
You Can Help
Please Consider a Donation!
Your generous donations will continue to aid our mission to help fund research to develop treatments and a cure for SCAR-15.